# US 6,727,288 B2 · Method for treating bone fracture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,288 B2
- Document ID: US6727288B2
- Status: Granted
- Kind: B2
- Application number: 10/039,194
- Filed: 2001-12-31
- Published: 2002-11-14
- Granted: 2004-04-27
- Earliest claimed: 2001-03-07
- Assignees: Juneng Industry Co., Ltd.
- Inventors: Kai Yu; Zhiwen Wang; Xiangguo Dai
- Web page: https://patentgrep.com/patent/US6727288B2

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a method for treating or preventing bone fracture, which comprises administering an effective amount of calcium L-threonate to a subject in need of such prevention or treatment. It had been found from experiments that calcium L-threonate could not only promote proliferation, differentiation and mineralization of osteoblasts, but also could promote the expression of collagen I mRNA of osteoblasts cultured in vitro. Accordingly it facilitated bone fracture healing and increased bone density and mechanical performance, so as to prevent or treat bone fracture.

## Claims

### Claim 1

A method for treating bone fracture, comprising the step of administering an effective amount of calcium L-threonate to a subject in need of such treatment.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the bone fracture is a traumatic fracture.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the bone fracture is a pathological fracture.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the calcium L-threonate is administered at a dosage of from about 0.5 to 12 gram/day.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the calcium L-threonate is administered at a dosage of from about 3 to 7 gram/day.

### Claim 6 (depends on 1)

The method according to claim 1, wherein said calcium L-threonate is administered orally.
